US Stock MarketDetailed Quotes

Lisata Therapeutics (LSTA)

Watchlist
  • 3.170
  • +0.090+2.92%
Close May 15 15:59 ET
  • 3.170
  • 0.0000.00%
Post 16:04 ET
28.87MMarket Cap-1.70P/E (TTM)

Lisata Therapeutics (LSTA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.93%-3.08M
17.60%-15.95M
28.25%-3.25M
-32.72%-3.34M
25.12%-3.96M
23.13%-5.4M
3.37%-19.36M
-11.28%-4.53M
29.72%-2.52M
-26.27%-5.28M
Net income from continuing operations
4.97%-4.49M
17.01%-16.59M
35.92%-2.95M
13.81%-4.25M
7.63%-4.66M
12.53%-4.72M
4.10%-19.99M
14.07%-4.61M
6.29%-4.93M
-25.25%-5.04M
Operating gains losses
----
----
----
----
----
----
4,233.33%130K
--0
--30K
--0
Depreciation and amortization
-95.35%2K
-16.09%146K
-63.41%15K
4.76%44K
-2.22%44K
-6.52%43K
-7.94%174K
-12.77%41K
-10.64%42K
-4.26%45K
Change In working capital
185.95%1.04M
-47.42%-1.29M
-125.63%-1.16M
-69.34%645K
213.40%440K
41.66%-1.21M
-88.96%-873K
-150.15%-515K
30.93%2.1M
26.52%-388K
-Change in receivables
--0
144.56%401K
100.33%3K
---1K
--249K
--150K
---900K
---900K
--0
--0
-Change in prepaid assets
99.26%807K
-12.91%742K
146.53%335K
-82.12%344K
-165.77%-342K
146.44%405K
203.40%852K
-41.18%-720K
127.15%1.92M
5.91%520K
-Change in payables and accrued expense
112.88%233K
-158.29%-2.57M
-241.38%-1.5M
83.94%252K
151.26%487K
-45.53%-1.81M
-1,230.68%-995K
-23.83%1.06M
-81.66%137K
1.96%-950K
-Change in other current assets
--0
-17.65%140K
--0
16.28%50K
9.52%46K
7.32%44K
-37.96%170K
-69.44%44K
230.77%43K
184.00%42K
Cash from discontinued investing activities
Operating cash flow
42.93%-3.08M
17.60%-15.95M
28.25%-3.25M
-32.72%-3.34M
25.12%-3.96M
23.13%-5.4M
3.37%-19.36M
-11.28%-4.53M
29.72%-2.52M
-26.27%-5.28M
Investing cash flow
Cash flow from continuing investing activities
0
14.00%15.09M
0
181.68%5.15M
-95.69%505K
46.54%9.43M
30.99%13.23M
124.31%1.39M
-151.46%-6.31M
1,715.59%11.71M
Net PPE purchase and sale
--0
---28K
--0
--0
--0
---28K
--0
--0
--0
--0
Net business purchase and sale
----
--0
--0
--0
--0
--0
---130K
--0
---30K
--0
Net investment purchase and sale
--0
13.10%15.11M
--0
182.07%5.15M
-95.69%505K
44.72%9.46M
32.28%13.36M
124.31%1.39M
-151.22%-6.28M
1,715.59%11.71M
Cash from discontinued investing activities
Investing cash flow
--0
14.00%15.09M
--0
181.68%5.15M
-95.69%505K
46.54%9.43M
30.99%13.23M
124.31%1.39M
-151.46%-6.31M
1,715.59%11.71M
Financing cash flow
Cash flow from continuing financing activities
886.96%181K
390.78%599K
313.54%205K
353K
100.00%64K
83.80%-23K
-153.51%-206K
-500.00%-96K
0
-92.92%32K
Net common stock issuance
--0
1,141.18%844K
469.44%205K
--353K
131.25%74K
--212K
-78.82%68K
50.00%36K
--0
--32K
Proceeds from stock option exercised by employees
4,150.00%340K
--8K
--0
--0
--0
--8K
--0
--0
--0
--0
Net other financing activities
34.57%-159K
7.66%-253K
--0
--0
---10K
-71.13%-243K
-201.10%-274K
---132K
--0
--0
Cash from discontinued financing activities
Financing cash flow
886.96%181K
390.78%599K
313.54%205K
--353K
100.00%64K
83.80%-23K
-153.51%-206K
-500.00%-96K
--0
-92.92%32K
Net cash flow
Beginning cash position
-1.56%15.96M
-28.26%16.21M
-2.62%19M
-40.50%16.84M
-7.28%20.22M
-28.26%16.21M
-29.74%22.59M
-39.84%19.51M
19.43%28.29M
-22.55%21.81M
Current changes in cash
-172.44%-2.9M
95.83%-264K
5.90%-3.04M
124.49%2.16M
-152.41%-3.39M
646.52%4.01M
33.69%-6.33M
66.85%-3.24M
-201.85%-8.82M
244.99%6.46M
Effect of exchange rate changes
200.00%6K
120.00%11K
103.08%2K
-94.87%2K
-80.77%5K
103.64%2K
-243.75%-55K
14.47%-65K
-48.00%39K
425.00%26K
End cash Position
-35.40%13.06M
-1.56%15.96M
-1.56%15.96M
-2.62%19M
-40.50%16.84M
-7.28%20.22M
-28.26%16.21M
-28.26%16.21M
-39.84%19.51M
19.43%28.29M
Free cash flow
43.22%-3.08M
17.46%-15.98M
28.25%-3.25M
-32.72%-3.34M
25.12%-3.96M
22.73%-5.43M
3.37%-19.36M
-11.28%-4.53M
29.72%-2.52M
-26.27%-5.28M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.93%-3.08M17.60%-15.95M28.25%-3.25M-32.72%-3.34M25.12%-3.96M23.13%-5.4M3.37%-19.36M-11.28%-4.53M29.72%-2.52M-26.27%-5.28M
Net income from continuing operations 4.97%-4.49M17.01%-16.59M35.92%-2.95M13.81%-4.25M7.63%-4.66M12.53%-4.72M4.10%-19.99M14.07%-4.61M6.29%-4.93M-25.25%-5.04M
Operating gains losses ------------------------4,233.33%130K--0--30K--0
Depreciation and amortization -95.35%2K-16.09%146K-63.41%15K4.76%44K-2.22%44K-6.52%43K-7.94%174K-12.77%41K-10.64%42K-4.26%45K
Change In working capital 185.95%1.04M-47.42%-1.29M-125.63%-1.16M-69.34%645K213.40%440K41.66%-1.21M-88.96%-873K-150.15%-515K30.93%2.1M26.52%-388K
-Change in receivables --0144.56%401K100.33%3K---1K--249K--150K---900K---900K--0--0
-Change in prepaid assets 99.26%807K-12.91%742K146.53%335K-82.12%344K-165.77%-342K146.44%405K203.40%852K-41.18%-720K127.15%1.92M5.91%520K
-Change in payables and accrued expense 112.88%233K-158.29%-2.57M-241.38%-1.5M83.94%252K151.26%487K-45.53%-1.81M-1,230.68%-995K-23.83%1.06M-81.66%137K1.96%-950K
-Change in other current assets --0-17.65%140K--016.28%50K9.52%46K7.32%44K-37.96%170K-69.44%44K230.77%43K184.00%42K
Cash from discontinued investing activities
Operating cash flow 42.93%-3.08M17.60%-15.95M28.25%-3.25M-32.72%-3.34M25.12%-3.96M23.13%-5.4M3.37%-19.36M-11.28%-4.53M29.72%-2.52M-26.27%-5.28M
Investing cash flow
Cash flow from continuing investing activities 014.00%15.09M0181.68%5.15M-95.69%505K46.54%9.43M30.99%13.23M124.31%1.39M-151.46%-6.31M1,715.59%11.71M
Net PPE purchase and sale --0---28K--0--0--0---28K--0--0--0--0
Net business purchase and sale ------0--0--0--0--0---130K--0---30K--0
Net investment purchase and sale --013.10%15.11M--0182.07%5.15M-95.69%505K44.72%9.46M32.28%13.36M124.31%1.39M-151.22%-6.28M1,715.59%11.71M
Cash from discontinued investing activities
Investing cash flow --014.00%15.09M--0181.68%5.15M-95.69%505K46.54%9.43M30.99%13.23M124.31%1.39M-151.46%-6.31M1,715.59%11.71M
Financing cash flow
Cash flow from continuing financing activities 886.96%181K390.78%599K313.54%205K353K100.00%64K83.80%-23K-153.51%-206K-500.00%-96K0-92.92%32K
Net common stock issuance --01,141.18%844K469.44%205K--353K131.25%74K--212K-78.82%68K50.00%36K--0--32K
Proceeds from stock option exercised by employees 4,150.00%340K--8K--0--0--0--8K--0--0--0--0
Net other financing activities 34.57%-159K7.66%-253K--0--0---10K-71.13%-243K-201.10%-274K---132K--0--0
Cash from discontinued financing activities
Financing cash flow 886.96%181K390.78%599K313.54%205K--353K100.00%64K83.80%-23K-153.51%-206K-500.00%-96K--0-92.92%32K
Net cash flow
Beginning cash position -1.56%15.96M-28.26%16.21M-2.62%19M-40.50%16.84M-7.28%20.22M-28.26%16.21M-29.74%22.59M-39.84%19.51M19.43%28.29M-22.55%21.81M
Current changes in cash -172.44%-2.9M95.83%-264K5.90%-3.04M124.49%2.16M-152.41%-3.39M646.52%4.01M33.69%-6.33M66.85%-3.24M-201.85%-8.82M244.99%6.46M
Effect of exchange rate changes 200.00%6K120.00%11K103.08%2K-94.87%2K-80.77%5K103.64%2K-243.75%-55K14.47%-65K-48.00%39K425.00%26K
End cash Position -35.40%13.06M-1.56%15.96M-1.56%15.96M-2.62%19M-40.50%16.84M-7.28%20.22M-28.26%16.21M-28.26%16.21M-39.84%19.51M19.43%28.29M
Free cash flow 43.22%-3.08M17.46%-15.98M28.25%-3.25M-32.72%-3.34M25.12%-3.96M22.73%-5.43M3.37%-19.36M-11.28%-4.53M29.72%-2.52M-26.27%-5.28M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More